CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
122 hedge funds and large institutions have $524M invested in Clovis Oncology, Inc. in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 29 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
-13
Holders Change %
-9.63%
% of All Funds
3.26%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
25
Increased
49
Reduced
29
Closed
37
Calls
$13.6M
Puts
$14.8M
Net Calls
-$1.25M
Net Calls Change
-$35.2M
Top Buyers
| 1 |
CCM
1
Consonance Capital Management
New York
|
$40.3M |
| 2 |
2
Morgan Stanley
New York
|
$20.2M |
| 3 |
3
Goldman Sachs
New York
|
$24M |
| 4 |
SC
4
Samlyn Capital
New York
|
$9.31M |
| 5 |
HM
5
HealthCor Management
New York
|
$36.4M |
